UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Identifying monoclonal gammopathy of undetermined significance from electronic health records

Cancer reports, 2023-03, Vol.6 (3), p.e1755-n/a

2023

Volltextzugriff (PDF)

15. Single-cell discovery and multi-omic characterization of therapeutic targets in multiple myeloma

Journal of bone oncology, 2024-04, Vol.45, p.100553, Article 100553

2024

Volltextzugriff (PDF)

Abstract 716: Telehealth use among multiple myeloma patients during the COVID-19 pandemic

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.716-716

2021

Volltextzugriff (PDF)

Impact of Health Insurance and Access to Autologous Stem Cell Transplantation (ASCT) on Racial Inequity in Overall Survival (OS) Among Patients with Multiple Myeloma (MM)

Blood, 2023-11, Vol.142 (Supplement 1), p.4730-4730

2023

Volltextzugriff (PDF)

Patient-reported experience platform identifies discordance between guidelines and real-world practice: Maintenance therapy for high-risk multiple myeloma

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e20022-e20022

2021

Volltextzugriff (PDF)

Patient-reported efficacy and toxicity in CAR T-cell therapy for multiple myeloma via Internet-based platforms

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e20024-e20024

2021

Volltextzugriff (PDF)

Experience With an All-Polyethylene Total Knee Arthroplasty in Younger, Active Patients With Follow-up From 2 to 11 Years

The Journal of arthroplasty, 2005-10, Vol.20 (7 Suppl 3), p.7-11

2005

Volltextzugriff (PDF)

Co-evolution of tumor and immune cells during progression of multiple myeloma

Nature communications, 2021-05, Vol.12 (1), p.2559-2559, Article 2559

2021

Volltextzugriff (PDF)

Needle in a Haystack: A Pilot Study Combining Single-Cell Multiomics with Clinical NGS-MRD Sequencing to Search for Circulating Clonotypic Dedifferentiated Myeloma Cells

Blood, 2022-11, Vol.140 (Supplement 1), p.9945-9946

2022

Volltextzugriff (PDF)

Dramatic Resolution of HLH after Treatment with the JAK 1/2 Inhibitor, Ruxolitinib

Blood, 2019-11, Vol.134 (Supplement_1), p.2325-2325

2019

Volltextzugriff (PDF)

Clonal Hematopoiesis Is Associated with Severe Cytokine Release Syndrome in Patients Treated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy

Blood, 2023-11, Vol.142 (Supplement 1), p.4814-4814

2023

Volltextzugriff (PDF)

Prior Immune Effector Cell Therapy, Is Not Associated with an Increased Infectious Risk of Subsequent Bispecific Antibody Therapy for Multiple Myeloma

Blood, 2023-11, Vol.142 (Supplement 1), p.1987-1987

2023

Volltextzugriff (PDF)

P-264 A phase 1b study of isatuximab and bendamustine for triple-class refractory multiple myeloma

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S181-S181

2023

Volltextzugriff (PDF)

Duvelisib for Critically-Ill Patients with COVID-19 Disease: An Investigator-Initiated, Randomized, Placebo-Controlled Double-Blind Pilot Trial

Blood, 2022-11, Vol.140 (Supplement 1), p.11185-11186

2022

Volltextzugriff (PDF)

Oedipus or Orestes? Homosexual Men, Their Mothers, and Other Women Revisited

Journal of the American Psychoanalytic Association, 2001, Vol.49 (4), p.1269-1287

Goldsmith, Scott, J.

2001

Volltextzugriff (PDF)

The Ire of IRE1α: Overexpression of IRE1α at Myeloma Diagnosis Is Associated with Decreased Survival While Downregulation of IRE1α Expression Is Predictive of Therapy Resistance

Blood, 2019-11, Vol.134 (Supplement_1), p.4351-4351

2019

Volltextzugriff (PDF)

Cytomegalovirus (CMV) disease in peripheral blood (PB) allogeneic hematopoietic cell transplant (HCT) with post-transplant cyclophosphamide (PT-Cy)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e18538-e18538

2016

Volltextzugriff (PDF)

Impact of KIR-ligand mismatch on outcomes after peripheral blood haploidentical hematopoietic cell transplantation

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.7051-7051

2016

Volltextzugriff (PDF)

A Single Center Retrospective Analysis of Daratumumab, Pomalidomide, and Dexamethasone As a Second Line Therapy for Multiple Myeloma

Blood, 2020-11, Vol.136 (Supplement 1), p.31-32

2020

Volltextzugriff (PDF)

Herpesvirus Entry Mediator As a Novel Therapeutic Target in Multiple Myeloma

Blood, 2023-11, Vol.142 (Supplement 1), p.3296-3296

2023

Volltextzugriff (PDF)

P-347 Longitudinal profiling identifies genetic mechanisms of resistance to four different drug classes in a t(4;14) positive patient

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S230-S231

2023

Volltextzugriff (PDF)

A single center retrospective study of daratumumab, pomalidomide, and dexamethasone as 2nd-line therapy in multiple myeloma

Leukemia & lymphoma, 2021-10, Vol.62 (12), p.3043-3046

2021

Volltextzugriff (PDF)

Utilization of Autologous Stem Cell Transplantation in Older Patients with Newly Diagnosed Multiple Myeloma

Blood, 2019-11, Vol.134 (Supplement_1), p.5701-5701

2019

Volltextzugriff (PDF)

P-275 Targeting HVEM Using a Monoclonal Antibody Shows Therapeutic Promise in Multiple Myeloma

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S194-S195

2024

Volltextzugriff (PDF)

P-031 Phase I Study to Evaluate Cellular Immunotherapy Using CS-1 Targeting Autologous CAR T Cells in Patients with Relapsed and Refractory Multiple Myeloma (RRMM)

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S58-S59

2024

Volltextzugriff (PDF)

26 – 50 von 392

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(320)
Mit Volltextzugriff
(332)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(392)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Identifying monoclonal gammopathy of undetermined significance from electronic health records

15. Single-cell discovery and multi-omic characterization of therapeutic targets in multiple myeloma

Abstract 716: Telehealth use among multiple myeloma patients during the COVID-19 pandemic

Impact of Health Insurance and Access to Autologous Stem Cell Transplantation (ASCT) on Racial Inequity in Overall Survival (OS) Among Patients with Multiple Myeloma (MM)

Patient-reported experience platform identifies discordance between guidelines and real-world practice: Maintenance therapy for high-risk multiple myeloma

Patient-reported efficacy and toxicity in CAR T-cell therapy for multiple myeloma via Internet-based platforms

Experience With an All-Polyethylene Total Knee Arthroplasty in Younger, Active Patients With Follow-up From 2 to 11 Years

Co-evolution of tumor and immune cells during progression of multiple myeloma

Needle in a Haystack: A Pilot Study Combining Single-Cell Multiomics with Clinical NGS-MRD Sequencing to Search for Circulating Clonotypic Dedifferentiated Myeloma Cells

Dramatic Resolution of HLH after Treatment with the JAK 1/2 Inhibitor, Ruxolitinib

Clonal Hematopoiesis Is Associated with Severe Cytokine Release Syndrome in Patients Treated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy

Prior Immune Effector Cell Therapy, Is Not Associated with an Increased Infectious Risk of Subsequent Bispecific Antibody Therapy for Multiple Myeloma

P-264 A phase 1b study of isatuximab and bendamustine for triple-class refractory multiple myeloma

Duvelisib for Critically-Ill Patients with COVID-19 Disease: An Investigator-Initiated, Randomized, Placebo-Controlled Double-Blind Pilot Trial

Oedipus or Orestes? Homosexual Men, Their Mothers, and Other Women Revisited

The Ire of IRE1α: Overexpression of IRE1α at Myeloma Diagnosis Is Associated with Decreased Survival While Downregulation of IRE1α Expression Is Predictive of Therapy Resistance

Cytomegalovirus (CMV) disease in peripheral blood (PB) allogeneic hematopoietic cell transplant (HCT) with post-transplant cyclophosphamide (PT-Cy)

Impact of KIR-ligand mismatch on outcomes after peripheral blood haploidentical hematopoietic cell transplantation

A Single Center Retrospective Analysis of Daratumumab, Pomalidomide, and Dexamethasone As a Second Line Therapy for Multiple Myeloma

Herpesvirus Entry Mediator As a Novel Therapeutic Target in Multiple Myeloma

P-347 Longitudinal profiling identifies genetic mechanisms of resistance to four different drug classes in a t(4;14) positive patient

A single center retrospective study of daratumumab, pomalidomide, and dexamethasone as 2nd-line therapy in multiple myeloma

Utilization of Autologous Stem Cell Transplantation in Older Patients with Newly Diagnosed Multiple Myeloma

P-275 Targeting HVEM Using a Monoclonal Antibody Shows Therapeutic Promise in Multiple Myeloma

P-031 Phase I Study to Evaluate Cellular Immunotherapy Using CS-1 Targeting Autologous CAR T Cells in Patients with Relapsed and Refractory Multiple Myeloma (RRMM)

Suchergebnisse filtern